AcquisitionOther
Obsidian Therapeutics acquired Galera Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
Obsidian Therapeutics -> Galera Therapeutics · $350 million private placement financing
To combine in all-stock transaction to advance Obsidian's pipeline of novel engineered TIL cell therapies and provide clinical development funding.
Open source record (SEC) ↗